L-862

N/A

Report date: 2025/06/11 11:17:22
NME

Base Information

Drug NameL-862
Drug Alias NameTRPC3/TRPC6 inhibitors (Kyoto Univ/National Institute of Biomedical Innovation/Osaka Univ/Kyushu Univ/National Institute for Physiological Sciences)L-687L-862
ClassificationSmall molecules
Mechanisms of ActionShort transient receptor potential channel 3 antagonistsShort transient receptor potential channel 6 inhibitors
TargetsShort transient receptor potential channel 6Short transient receptor potential channel 3
Therapy Area/IndicationsFibrosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesKyoto University
China Registration ClassN/A

Develop Information

Active CompaniesNational Institute for Physiological SciencesNational Institute Of Biomedical InnovationKyoto University +[5] 
Inactive CompaniesN/A
Active IndicationsFibrosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A